Milena Kalaitsidou

CAR T-cell therapy: toxicity and the relevance of preclinical models.

D. Gilham, G. Kueberuwa, Milena Kalaitsidou, 2015, Immunotherapy.

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity

D. Gilham, R. Hawkins, E. Cheadle, 2017, Molecular therapy oncolytics.

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

D. Gilham, G. Owens, R. Edmondson, 2017, Journal of immunotherapy.

Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy

J. Drijfhout, P. Stern, D. Gilham, 2012, Cancer Immunology, Immunotherapy.

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

D. Gilham, R. Hawkins, G. Kueberuwa, 2018, Journal of visualized experiments : JoVE.

Engineering strategies to optimise adoptive cell therapy in ovarian cancer.

G. Kueberuwa, Milena Kalaitsidou, Catarina Guerra, 2023, Cancer treatment reviews.

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

A. Udyavar, Eric H. Gschweng, S. Sukumaran, 2023, Frontiers in immunology.